ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682237; 2) Community: the network communities that were significantly associated with the response to NSC 682237; 3) Molecule: the relationships between components within communities and NSC 682237; 4) MDR: the compounds that were significantly associated with the NSC 682237.

NSC Compound Enrichment Correlation
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.000161224791712088 0.23013702
NSC 680399 Null 0.000161224791712088 0.47610745
NSC 76919 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- 0.000220702896059653 0.21240792
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.00070132188671658 0.1926018
NSC 660029 Null 0.00070132188671658 0.16566911
NSC 762864 Null 0.000880521445136051 0.36030778
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.000880521445136057 0.37826992
NSC 679509 Null 0.000880521445136057 0.21286664
NSC 45236 Null 0.000931492155975116 0.019020493
NSC 681632 Camptothecin Derivative 0.000931492155975116 0.20968761
Total:42  Current:1    [First] [Prev] [Next] [Last]